#ThinkSabio US Market Morning Brief

Pre-Market Gainers
$SMMT +32%: Merck stock falls as a rival beats its Keytruda cancer drug in trial.
$TERN +29%: Terns Pharmaceuticals reports positive Phase 1 results for obesity treatment TERN-601.
$INBS +28%: Intelligent Bio Solutions progresses towards FDA 510(k) submission.
$IVP +25%: Inspire Veterinary Partners announces non-binding acquisition proposal of http://Vetsie.ai.

Pre-Market Decliners:
$CCCC -19%: C4 Therapeutics to present preliminary Phase 1 data for CFT1946 at ESMO Congress 2024.
$CURR -13%.

Pre-Market Penny Gainers:
$TNXP +37%: Tonix Pharmaceuticals presents Mpox vaccine data at Immunology Symposium.
$HYZN +20%: Hyzon announces 1-for-50 reverse stock split.

Headlines:
$NVDA: Nvidia-backed startup Sakana AI seeks more partnerships in Japan.
$LLY: Lilly appoints Lucas Montarce as CFO.
$MRK: Ifinatamab Deruxtecan shows promising results in small cell lung cancer trial.